A Seamless Specialty Drug Management Program

Covers both pharmacy and medical benefit drugs

VIVIO qClinicals™ – model-based care management

Real world effectiveness primary driver

No arbitrary formularies

PA replaced with individualized care planning

Transparent procurement model, lowest cost acquisition

Simple & transparent fee

Comprehensive
care

VIVIO Precision Care™ erases the arbitrary line between pharmacy benefit and medical benefit and supports both for truly personalized care.

The Right Care

No need for arbitrary formularies that exclude certain drugs to maximize drug rebates from manufacturers.

Instead we use data and analytics to make drugs available based on real-world effectiveness and individual patient needs.

Simple care

VIVIO’s member concierge team is there to help with any questions on therapy, plan design, shipping or anything else

Whatever the problem is, it is ours to solve.

High cost specialty conditions

Managed one person at a time.

Rheumatoid Arthritis

Affects 1.5M Americans
3X more common for women
Staying active can help reduce pain and protect joint health

Affects 7.5M Americans
Most likely appears between ages 15-35
Up to 30% will develop psoriatic arthritis

Psoriasis

Crohn’s Disease

A type of inflammatory bowel disease affecting 750K Americans
Children are twice as likely to be diagnosed
2X risk for smokers

1.7M newly diagnosed Americans in 2019
600K deaths in 2019
The cancer death rate has fallen 27% since the peak in 1991

Cancer

HIV

Affects 1.1M Americans
14% are unaware of their condition
Without treatment, HIV usually progresses to AIDS in 10 years, or sooner in some people

Affects 1M Americans
Rate in northern states is 2X that of southern states below 37○ Parallel
2-3X more common for women

Multiple Sclerosis

Hepatitis C

Affects 3.5M Americans
15-45% get better without receiving treatment
Antiviral treatment cures > 90% of people treated

Affects 8% of Americans
Prevalence in children, is higher than adults
Causes 1.3M ER visits, 450K hospitalizations and 3,500 deaths/year

Severe Asthma/CIU

Cystic Fibrosis

Affects 30K Americans
More than 75% are diagnosed by age 2
More than half of CF population is age 18 or older

Affects 20K Americans
Median diagnosis age is between 1 and 36 months depending on severity
1/3 of people have no known family history

Hemophilia

Enzyme Replacement

8K people with Fabry disease
6K people with Gaucher disease
Other conditions include Wolman disease, MPS and Pompe disease

50K people with Growth Hormone deficiency
Can be congenital or acquired in childhood or adult life
Side effects in children include sparse hair growth and frontal recession

Growth Hormone Deficiency (HGH)

Technology drives lower costs and better outcomes

VIVIO Precision Care™ is our proprietary specialty drug management program powered by VIVIO qClinicals™, our continuous improvement care model.

We’re transparent

You own your own data and you’re free to examine any underlying contact at anytime. Our only revenue source is our PMPM fees, and that’s it.

Save like our other customers

Get Started